ANL Latest Press Releases

-- August 14, 2026 --

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress Globe Newswire 7:00 AM

-- August 3, 2026 --

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia Globe Newswire 7:00 AM

-- July 16, 2026 --

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025 Globe Newswire 7:00 AM

-- July 13, 2026 --

Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists Globe Newswire 7:00 AM

-- April 16, 2026 --

Adlai Nortye Announces $150.0 Million Private Placement Equity Financing Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software